| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-14 | 2025-03-28 | 2022-03-11 |
| Revenue | 41.87 | 24.65 | 0 |
| Cost of Revenue | 11.09 | 6.66 | 0 |
| Gross Profit | 30.78 | 17.99 | 0 |
| Operating Expenses | 34.14 | 18.59 | 4.44 |
| Research & Development | 9.51 | 5.9 | 0 |
| Selling, General and Administrative | 22.03 | 12.69 | 4.44 |
| Other Operating Expenses | 2.6 | 0 | 0 |
| Operating Income | -3.35 | -0.6 | -4.44 |
| Net Non-Operating Interest | -3.14 | 2.21 | 12.18 |
| Interest Income | 0.041 | 0.006 | 0.036 |
| Interest Expense | 3.18 | -2.21 | -12.14 |
| Equity & Other Income/(Expense) | -10.6 | -3.49 | -0.036 |
| Income Before Tax | -17.09 | -1.87 | 7.71 |
| Income Tax Expense | 0.003 | 0.003 | -12.14 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | -17.1 | -1.88 | 19.85 |
| Depreciation and Amortization | -11.37 | 0 | 12.14 |
| EBITDA | -14.72 | -0.6 | 7.71 |
| Earnings Per Share (EPS) | -1.03 | -0.04 | 0.79 |
| Diluted Earnings Per Share | -0.615 | -0.04 | 0.79 |
| Weighted Average Shares Outstanding | 45.72 | 45,946 | 25 |
| Diluted Weighted Average Shares Outstanding | 47.79 | 45,946 | 25 |
